Puerarin is a hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 7 and 4' and a beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage.
定義
Puerarin is a hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 7 and 4' and a beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage. It has a role as an autophagy inducer, a ferroptosis inhibitor, an antioxidant, an antipyretic, an anti-inflammatory agent, a plant metabolite and a cardioprotective agent. It is a C-glycosyl compound and a hydroxyisoflavone. It is functionally related to an isoflavone. It is a conjugate acid of a puerarin(1-).
出典: PubChem
米国FDA 物質登録 · UNII Z9W8997416 · 登録名 PUERARIN · 単一の化学物質
化粧品での役割
安全性・規制情報
Other restriction: ban substances that deplete the ozone layer
出典: EU CosIng 成分リスト
詳しい資料 — 表示名・識別番号・物性・試験記録・文献
別名・識別情報
- CAS No.化学物質登録番号
- 3681-99-0
- DTXSID米国EPA化学物質番号
- DTXSID30958020
- DTXCID米国EPA化合物番号
- DTXCID001385940
- IUPAC
- (1S)-1,5-Anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]-D-glucitol
- 分子式
- C21H20O9
- 分子量
- 416.382 g/mol
製品が実際に使っている用途
関連文献
- Puerarin blocks the aging phenotype in human dermal fibroblasts · 2021
- Puerarin blocks aging phenotype in cultured human dermal fibroblasts · 2020
- Study on preparation and in vitrotransdermal properties of Puerarin Microemulsion · 2013
- Study on the Effect of Menthol on Mucosal Permeability of Puerarin in vitro · 2012
- Skin penetration test for a puerarin transdermal drug delivery system in vitro · 2009